Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gentsch

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Pharmacopsychiatry|May 1, 1988
WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative StudyP Bech, L Eplov, M Gastpar, et al.
Behavioural Brain Research|August 11, 2004
The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-mazeR J Rodgers, C Gentsch, D Hoyer, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodentsW P Spooren, A Vassout, H C Neijt, et al.
NMR in Biomedicine|May 18, 2001
Non-invasive, quantitative assessment of the anatomical phenotype of corticotropin-releasing factor-overexpressing mice by MRIN Beckmann, C Gentsch, D Baumann, et al.
NMR in Biomedicine|May 18, 2001
Current awarenessN Beckmann, C Gentsch, D Baumann, et al.
Amino Acids|October 10, 2002
In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review articleR Kuhn, A Pagano, N Stoehr, et al.
Journal of Medicinal Chemistry|August 18, 1995
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonistsW Froestl, S J Mickel, R G Hall, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline typeA von Sprecher, M Gerspacher, A Beck, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Pharmacopsychiatry|May 1, 1988
WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative StudyP Bech, L Eplov, M Gastpar, et al.
Behavioural Brain Research|August 11, 2004
The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-mazeR J Rodgers, C Gentsch, D Hoyer, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodentsW P Spooren, A Vassout, H C Neijt, et al.
NMR in Biomedicine|May 18, 2001
Non-invasive, quantitative assessment of the anatomical phenotype of corticotropin-releasing factor-overexpressing mice by MRIN Beckmann, C Gentsch, D Baumann, et al.
NMR in Biomedicine|May 18, 2001
Current awarenessN Beckmann, C Gentsch, D Baumann, et al.
Amino Acids|October 10, 2002
In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review articleR Kuhn, A Pagano, N Stoehr, et al.
Journal of Medicinal Chemistry|August 18, 1995
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonistsW Froestl, S J Mickel, R G Hall, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline typeA von Sprecher, M Gerspacher, A Beck, et al.
Pageof 5